FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022806544> ?p ?o ?g. }

• W2022806544 endingPage "33" @default.
• W2022806544 startingPage "27" @default.
• W2022806544 abstract "Past studies have shown antagonists of excitatory amino acid receptors, both N-methyl-d-aspartate (NMDA) and non-NMDA, to produce an antinociceptive effect in vitro and in vivo. Additionally, NMDA receptor antagonists have been demonstrated to prevent morphine tolerance. We had found that one NMDA receptor antagonist, ketamine, potentiates morphine's analgesic effect in post-operative patients. Our latest experiment was performed to examine the modulatory effect of competitive and non-competitive NMDA receptor antagonists on morphine antinociception and tolerance. A PE10 catheter was intrathecally (i.t.) implanted in male Sprague-Dawley rats for drug administration. The antinociceptive effect of morphine, d-(−)-2-amino-5-phosphonovaleric acid (D-AP5) and (+)-5-methyl-10,110-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801) was measured using the hot-water tail immersion test. Neither competitive nor non-competitive NMDA receptor antagonists had an antinociceptive effect by themselves, but they did potentiate the antinociceptive effect of morphine. Both D-AP5 (AD50 = 0.18 μg) and MK-801 (AD50 = 0.57 μg) shifted the antinociceptive dose-response curve of morphine (AD50 = 4.2 μg) to the left. Both D-AP5 (4 μg/h) and MK-801 (10 μg/h) when co-administered with i.t. morphine infusions (10 μg/h) also inhibited the development of tolerance. In [3H][d-Ala2,N-Me-Phe4,Gly5-ol]enkephalin ([3H]DAMGO) binding assays, MK-801 (Bax = 32.90 ± 3.33 fmol/mg) treatment prevented the down-regulation of μ-opioid receptor high-affinity sites induced by continuous morphine infusions alone (Bmax = 13.97 ± 1.47 fmol/mg). D-AP5 (Bmax = 20.78 ± 3.36 fmol/mg) did not prevent the reduction of μ-opioid receptor high-affinity sites. However, high-affinity sites in rats treated with D-AP5 and morphine displayed a higher affinity (KD = 0.45 ± 0.09 nM) than those of control animals (KD = 0.95 ± 0.08 nM). Results of this study indicate that competitive as well as non-competitive NMDA receptor antagonists enhance morphine's antinociceptive effect, and prevent the development of morphine tolerance. Thus, in our opinion, there opens a new frontier in clinical pain management, especially for those patients who require long-term opioid treatment for pain relief." @default.
• W2022806544 created "2016-06-24" @default.
• W2022806544 creator A5008613472 @default.
• W2022806544 creator A5016449773 @default.
• W2022806544 creator A5028617960 @default.
• W2022806544 creator A5049387183 @default.
• W2022806544 creator A5053645631 @default.
• W2022806544 date "1996-02-01" @default.
• W2022806544 modified "2023-09-25" @default.
• W2022806544 title "Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at μ-opioid receptors" @default.
• W2022806544 cites W1775749144 @default.
• W2022806544 cites W1906221302 @default.
• W2022806544 cites W1966428196 @default.
• W2022806544 cites W1975157090 @default.
• W2022806544 cites W1993097357 @default.
• W2022806544 cites W2004984343 @default.
• W2022806544 cites W2026329366 @default.
• W2022806544 cites W2033525233 @default.
• W2022806544 cites W2043813981 @default.
• W2022806544 cites W2046160546 @default.
• W2022806544 cites W2069696287 @default.
• W2022806544 cites W2074089364 @default.
• W2022806544 cites W2082474912 @default.
• W2022806544 cites W2104568075 @default.
• W2022806544 cites W2110945744 @default.
• W2022806544 cites W2111062311 @default.
• W2022806544 doi "https://doi.org/10.1016/0014-2999(95)00728-8" @default.
• W2022806544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8851162" @default.
• W2022806544 hasPublicationYear "1996" @default.
• W2022806544 type Work @default.
• W2022806544 sameAs 2022806544 @default.
• W2022806544 citedByCount "86" @default.
• W2022806544 countsByYear W20228065442012 @default.
• W2022806544 countsByYear W20228065442014 @default.
• W2022806544 countsByYear W20228065442015 @default.
• W2022806544 countsByYear W20228065442017 @default.
• W2022806544 countsByYear W20228065442019 @default.
• W2022806544 countsByYear W20228065442021 @default.
• W2022806544 countsByYear W20228065442022 @default.
• W2022806544 countsByYear W20228065442023 @default.
• W2022806544 crossrefType "journal-article" @default.
• W2022806544 hasAuthorship W2022806544A5008613472 @default.
• W2022806544 hasAuthorship W2022806544A5016449773 @default.
• W2022806544 hasAuthorship W2022806544A5028617960 @default.
• W2022806544 hasAuthorship W2022806544A5049387183 @default.
• W2022806544 hasAuthorship W2022806544A5053645631 @default.
• W2022806544 hasConcept C15490471 @default.
• W2022806544 hasConcept C170493617 @default.
• W2022806544 hasConcept C185592680 @default.
• W2022806544 hasConcept C2776401185 @default.
• W2022806544 hasConcept C2776885963 @default.
• W2022806544 hasConcept C2777389121 @default.
• W2022806544 hasConcept C2777803847 @default.
• W2022806544 hasConcept C2778122271 @default.
• W2022806544 hasConcept C2778750930 @default.
• W2022806544 hasConcept C2780820201 @default.
• W2022806544 hasConcept C2781063702 @default.
• W2022806544 hasConcept C55493867 @default.
• W2022806544 hasConcept C67018056 @default.
• W2022806544 hasConcept C71924100 @default.
• W2022806544 hasConcept C98274493 @default.
• W2022806544 hasConceptScore W2022806544C15490471 @default.
• W2022806544 hasConceptScore W2022806544C170493617 @default.
• W2022806544 hasConceptScore W2022806544C185592680 @default.
• W2022806544 hasConceptScore W2022806544C2776401185 @default.
• W2022806544 hasConceptScore W2022806544C2776885963 @default.
• W2022806544 hasConceptScore W2022806544C2777389121 @default.
• W2022806544 hasConceptScore W2022806544C2777803847 @default.
• W2022806544 hasConceptScore W2022806544C2778122271 @default.
• W2022806544 hasConceptScore W2022806544C2778750930 @default.
• W2022806544 hasConceptScore W2022806544C2780820201 @default.
• W2022806544 hasConceptScore W2022806544C2781063702 @default.
• W2022806544 hasConceptScore W2022806544C55493867 @default.
• W2022806544 hasConceptScore W2022806544C67018056 @default.
• W2022806544 hasConceptScore W2022806544C71924100 @default.
• W2022806544 hasConceptScore W2022806544C98274493 @default.
• W2022806544 hasIssue "1-2" @default.
• W2022806544 hasLocation W20228065441 @default.
• W2022806544 hasLocation W20228065442 @default.
• W2022806544 hasOpenAccess W2022806544 @default.
• W2022806544 hasPrimaryLocation W20228065441 @default.
• W2022806544 hasRelatedWork W1901249554 @default.
• W2022806544 hasRelatedWork W1977885061 @default.
• W2022806544 hasRelatedWork W2012852017 @default.
• W2022806544 hasRelatedWork W2018029543 @default.
• W2022806544 hasRelatedWork W2022703311 @default.
• W2022806544 hasRelatedWork W2031267513 @default.
• W2022806544 hasRelatedWork W2117209704 @default.
• W2022806544 hasRelatedWork W2990317114 @default.
• W2022806544 hasRelatedWork W4206871862 @default.
• W2022806544 hasRelatedWork W4287435042 @default.
• W2022806544 hasVolume "297" @default.
• W2022806544 isParatext "false" @default.
• W2022806544 isRetracted "false" @default.
• W2022806544 magId "2022806544" @default.
• W2022806544 workType "article" @default.